Interview with Prof. Michael Chopp – World Congress for Neurorehabilitation (WCNR) Vienna 2022
Interviewee: Professor Michael Chopp, Scientific Director of the Henry Ford Neuroscience Institute, the Zoltan J. Kovacs Chair in Neuroscience Research at Henry Ford Health, and Distinguished Professor of Physics at Oakland University, Michigan, United States.
Interviewer: Doria Constantinescu
Prof. Michael Chopp spoke passionately about the WCNR Congress, sharing his enthusiasm for people hailing from diverse parts of the world who come together to create a dynamic synergy of knowledge, opportunity, and growth, all with the common goal of advancing neurorehabilitation.
He emphasized the profound impact of events like the World Congress for NeuroRehabilitation (WCNR) in nurturing the development of new generations of specialists. Professor Michael Chopp stressed the importance not only of building upon existing knowledge but also of critically questioning it to drive innovation and progress.
During our conversation, Professor Chopp underscored the pivotal role of hybrid multidisciplinary events in advancing neurorehabilitation research and practice. He pinpointed the importance of treating the entire patient, recognizing that healing goes beyond addressing the injury itself and extends to the patient’s psychological well-being.
In particular, when discussing stroke rehabilitation, he emphasized the necessity of viewing the patient holistically, taking into account the systemic effects of the injury, and exploring how addressing secondary events can impact the patient’s overall recovery.
Professor Chopp delved into the domain of pharmacological support in stroke neurorehabilitation, highlighting the fact that there is no single “magic bullet” that can universally benefit every patient. He discussed the broader concept of “biological assistants/support” showcasing emerging therapies like stem cell treatments for recovery and the use of biological nanoparticles to enhance the rehabilitation process. Professor Michael Chopp emphasized the importance of considering the use of agents, whether pharmacologic or biologic, in combination with physical therapies or other modalities to maximize the effectiveness of neurorehabilitation.
Lastly, he expressed his joy at reuniting with colleagues after the challenges posed by the COVID-19 pandemic, underscoring the immense value of collaboration in advancing the field of neurorehabilitation.
